Ascorbate deficiency increases progression of shigellosis in guinea pigs and mice infection models

Jurate Skerniskyte1, Céline Mulet2, Antonin C André1,2

  • 1Institut de Biologie Moléculaire et Cellulaire, Architecture et Réactivité de l'ARN, Université de Strasbourg, Strasbourg, France.

Gut Microbes
|October 25, 2023
PubMed

Insights

Poor vitamin C status, or ascorbate deficiency, worsens shigellosis symptoms in guinea pigs and mice. This research introduces new rodent models for studying Shigella infection and immune responses.

Area of Science:

  • Microbiology
  • Immunology
  • Nutritional Science

Background:

  • Shigella species cause bacterial dysentery and shigellosis, primarily affecting children in developing nations.
  • Existing animal models fail to fully replicate shigellosis symptoms, hindering research on infection and vaccine development.
  • Mammals susceptible to Shigella, like humans and guinea pigs, cannot synthesize vitamin C (ascorbate).

Purpose of the Study:

  • To investigate if moderate ascorbate deficiency impacts the progression and severity of shigellosis.
  • To establish and utilize improved rodent models for studying Shigella infection dynamics.

Main Methods:

  • Optimized a low-ascorbate diet in guinea pigs to induce moderate vitamin C deficiency without causing scurvy.
  • Infected guinea pigs and Gulo-/- mice with various Shigella strains (S. sonnei, S. flexneri 5a, and 2a).
  • Assessed shigellosis symptom severity, neutrophil influx, bacterial dissemination, and epithelial penetration.

Main Results:

  • Moderate ascorbate deficiency significantly increased shigellosis symptom severity and duration (up to 48 hours) in guinea pigs.
  • Increased neutrophil infiltration into the colonic mucosa and lumen was observed in ascorbate-deficient guinea pigs.
  • Shigella demonstrated deeper organ penetration into the submucosal layer and bloodstream, and increased epithelial penetration in Gulo-/- mice.

Conclusions:

  • Moderate ascorbate deficiency exacerbates shigellosis, highlighting the role of vitamin C status in infection outcome.
  • The developed guinea pig and Gulo-/- mouse models offer valuable tools for studying Shigella pathogenesis and host-pathogen interactions.
  • These models facilitate further research into Shigella infection strategies and host immune responses, potentially aiding vaccine development.